BioXcel Therapeutics Provides an Update on its Ongoing Phase 3 SERENITY Trials

NEXT STORY
Zai Lab Announces Financial Results for Full Year Ended December 31, 2019 and Corporate Updates
PREV STORY
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Provides a Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Novelion Therapeutics Announces Presentation of Metreleptin Data at American Association of Clinical Endocrinology

VANCOUVER, British Columbia and CAMBRIDGE, Mass., May 05, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics ...

author_avatar
NASDAQ Market News

The cell-free protein expression market is expected to register a CAGR of nearly 6.1%, during the forecast period, 2019-2024

author_avatar
NASDAQ Market News

VBL Therapeutics to Report First Quarter 2018 Financial Results on May 17

author_avatar
NASDAQ Market News